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Abstract
Background The studies on the association of various midlife risk factors with reaching 90 years or more are scarce. We 
studied this association in a socioeconomically homogenous cohort of businessmen.
Methods The study consists of men (n = 970) from the Helsinki Businessmen Study cohort (born 1919–1928). Five major 
cardiovascular disease (CVD) risk factors (smoking, BMI, blood pressure, serum lipids, fasting glucose), consumption of 
alcohol and coffee, self-rated health and self-rated fitness, were assessed in 1974, at an average age of 50 years. The number 
of major risk factors was tested as a risk burden. The Charlson Comorbidity Index and the RAND-36 (SF-36) Physical and 
Mental health summary scores were calculated from surveys in year 2000, at age of 73 years. Mortality dates were retrieved 
through 31 March 2018 from the Population Information System of Finland.
Results 244 men survived to the age of 90 representing 25.2% of the study cohort. The survivors had less risk factor burden 
in midlife, and less morbidity and higher physical health summary score in 2000. Of those with five major risk factors only 
7% survived up to 90 years, whereas 51% of those without any risk factors reached that age. Single risk factors reducing 
odds of reaching 90 years were smoking (odds ratio [OR] 0.48, 95% confidence interval [CI] 0.34–0.67), glucose (0.66, 
0.49–0.88), BMI (0.63, 0.46–0.86), and cholesterol (0.71, 0.53–0.96).
Conclusion Lack of five major CVD risk factors in midlife strongly increased odds of reaching 90 years of age and also 
predicted factors related to successful ageing in late life.
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Introduction
Life expectancy has remarkably increased in Europe in the 
past decades [1]. Increasing numbers of people reach excep-
tional longevity, 90 years or more [1]. For example, in Fin-
land the probability of a 50-year old man of reaching the age 
of 90 has increased from 12 to 20% in 44 years [2].
Earlier studies have revealed the multitude of factors 
associated with longevity [3–11]: genetic factors may 
explain approximately 25% of the variation of lifespan, 
while healthy lifestyle habits in midlife also play an impor-
tant role [12].
For exceptional longevity, Yates et al. [13] studied the 
association of factors in age of 70 with survival till 90, and 
they revealed that the probability of reaching 90 years of age 
was 54% for those men who did not have any risk factors, 
and 4% for those who had five risk factors (smoking, diabe-
tes, obesity, hypertension, sedentary lifestyle) at mean age 
of 72. In addition, a Swedish prospective study [14] among 
a heterogeneous cohort showed that non-smoking, socioeco-
nomic status and general good health in midlife were strong 
predictors of survival to the age of 90.
To our knowledge, there are scarce prospective stud-
ies in homogeneous cohorts with very long follow-ups, 
especially exploring how combination of midlife major 
risk factors determines reaching 90  years of age. We 
investigated these midlife factors in a 44-year follow-up 
study of the Helsinki Businessmen Study cohort in which 
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socioeconomic effects on longevity are inherently adjusted 
for. To reflect the quality of longer life, we also compared 
some factors related to “successful” ageing at the age of 
73 years between those who did or did not reach 90 years 
of age.
Design and methods
Study population
HBS is a prospective cohort study of initially healthy Finn-
ish businessmen and executives born between 1919 and 
1934 (original n = 3490). Details of the study cohort have 
been described earlier [15]. The present study included 
those men who had the possibility to reach 90 years of age 
by March 2018 (born between 1919 and 1928) and had 
data of all major risk factors available in 1974 (n = 970). 
This sub-group has been followed-up for 44 years with 
mailed questionnaires, and clinical and laboratory assess-
ments. The follow-up was approved by the Ethics Com-
mittee of the Helsinki University Hospital, Department 
of Medicine, and all participants had provided informed 
consents.
Baseline measurements
Midlife factors were assessed in 1974, at an average 
age of 50 years. Clinical and laboratory examinations 
included body mass index (BMI, kg/m2), systolic and 
diastolic blood pressure (mmHg), total serum cholesterol 
(mmol/L), triglycerides (mmol/L) and 1-h post-load glu-
cose (mmol/L). In addition, the status of smoking and con-
sumption of coffee (cups/day) and alcohol (g/week) were 
asked in a questionnaire. Major cardiovascular risk factors 
included smoking status (yes/no), systolic blood pressure 
(≥ 144 mmHg), total cholesterol (> 6.2), body mass index 
(> 25) and fasting glucose (≥ 4.7). Median was used as a 
cut-point for risk in continuous variables. The number of 
major risk factors was tested as a risk burden.
Self-rated health (SRH) and self-rated fitness (SRF) 
were assessed by asking “What do you think about your 
present state of health/fitness; is it “very good”, “fairly 
good”, “average”, “fairly poor” or “very poor”. The status 
as “very good” and “fairly good” were combined in analy-
ses of SRH and SRF.
In 2000, men were sent a mailed questionnaire which 
included the survey of diseases and the validated Finnish 
version of the RAND-36 Health Survey [16]. The Charlson 
Comorbidity Index (CCI) was used as a measure of burden 
of disease [17]. The Physical and Mental health summary 
scores of the RAND-36 Health Survey were calculated and 
used in the analyses [18].
Mortality
The dates of death were drawn from the national Population 
Information System in March 2018. Between years 1974 and 
2018, 830 men of this sub-cohort had died. Of the deceased 
persons, 104 had reached 90 years of age whereas 726 had 
died before the age of 90 (Fig. 1).
Statistical analyses
The descriptive statistics are presented as means with SDs or 
as counts with percentages. Statistical comparisons between 
the groups were made using the t test or Chi square test. In 
the case of violation of the assumptions (e.g., non-normal-
ity), a bootstrap-type test was used. Kaplan–Meier method 
with age is the time scale used to estimate the cumulative 
survival. To determine characteristics associated with reach-
ing 90 years of age, multivariate logistic regression analysis 
was applied. The normality of the variables was tested using 
the Shapiro–Wilk W test. Stata 15.1 (StataCorp LP, College 
Station, TX, USA) was used for the analysis.
Results
The baseline characteristics of the study cohort in 1974 
are shown in Table 1. The mean age was 50 years (range 
46–55  years). 25.2% (n = 244) men of the cohort had 
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Fig. 1  Survival to age of 90 among HBS sub-cohort, n = 970
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reached 90 years or more by March 2018. Survivors to the 
age of 90 had less likely smoking history, and lower BMI 
than non-survivors. They had also lower levels of both sys-
tolic and diastolic blood pressure, fasting and 1-h glucose 
and serum lipids. They also consumed less alcohol. There 
were slight differences in midlife SRH and SRF between 
survivors to the age of 90 and non-survivors, but those 
were not significant.
In 2000, the Charlson comorbidity index was signifi-
cantly lower for men who reached 90 years of age. In addi-
tion, the Physical health summary score in RAND-36 was 
significantly higher for those who survived till age of 90, 
but differences in the Mental health summary score were 
not significantly different.
Of those who had none of the major risk factors, 51% 
reached 90 years of age. With one major risk factor, the 
percentage was 33%, with two risk factors 30%, with three 
risk factors 20%, and with four risk factors 18%. Whereas 
of those with five major risk factors only 7% survived until 
90. There was a linear relationship between the number 
of risk factors and reaching up to 90 years of age (Fig. 2).
In logistic regression analysis, significant risk factors 
were smoking (OR 0.48, 95% CI 0.34–0.67), glucose 
Table 1  Characteristics of study population (n = 970)
Continuous variables are mean (SD)
Variables in 1974 All n = 970 Reached 90 n = 244 Not reached 90
n = 726
p value for dif-
ference between 
groups
Age, years 50 (2.7) 50 (2.7) 50 (2.7) 0.90
Body mass index (kg/m2) 26.1 (2.8) 25.4 (2.6) 26.3 (2.9) < 0.001
Smoking n (%) 341 (35) 58 (24) 283 (40) < 0.001
Blood pressure (mmHg)
 Systolic 146 (20) 143 (20) 147 (20) 0.023
 Diastolic 94 (12) 92 (12) 94 (12) 0.004
Serum lipids (mmol/L)
 Cholesterol 6.37 (1.10) 6.13 (1.03) 6.47 (1.11) < 0.001
 Triglycerides 1.69 (0.89) 1.55 (0.75) 1.74 (0.93) 0.004
 1-h post-load glucose (mmol/L) 7.63 (2.30) 7.15 (2.12) 7.80 (2.33) < 0.001
 Alcohol (g/week) 161 (169) 136 (133) 170 (178) 0.008
 Coffee (cups/day) 4.1 (2.5) 3.8 (2.4) 4.1 (2.5) 0.13
 Self-rated health (SRH), rated as good, n (%) 461 (49) 120 (52) 341 (48) 0.69
 Self-rated fitness (SRF), rated as good, n (%) 317 (34) 87 (38) 230 (32) 0.069
Variables in 2000
 Physical Health summary 44 (9)
[515]
46 (8)
[208]
43 (10)
[307]
< 0.001
 Mental Health summary 53 (10)
[515]
54 (10)
[208]
53 (10)
[307]
0.39
 Charlson 1.5 (1.4)
[548]
1.1 (1.2)
[215]
1.8 (1.5)
[333]
< 0.001
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Fig. 2  Association of the amount of cardiovascular risk factors with 
survival to age of 90
Table 2  Odds for reaching 90 among the HBS cohort
Bold values indicate the significant values (p < .05)
a represents forward stepwise selection. Only those variables which 
entered the model are shown
Variable (adjusted for age) Multivariatea
OR (95% CI) p value
Smoking 0.48 (0.34–0.67) < 0.001
Systolic blood pressure  0.88 (0.65–1.19) 0.412
Body mass index  0.63 (0.46–0.86) 0.003
1-h post-load glucose  0.66 (0.49–0.88) 0.006
Total cholesterol  0.71 (0.53–0.96) 0.027
Alcohol 0.83 (0.60–1.14) 0.24
Self-rated health (SRH) 1.00 (0.69–1.44) 0.99
Self-rated fitness (SRF) 1.05 (0.72–1.55) 0.80
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(OR 0.66, 95% CI 0.49–0.88), BMI (OR 0.63, 95% CI 
0.46–0.86) and cholesterol (OR 0.71, 95% CI 0.53–0.96) 
whereas systolic blood pressure did not reach significance. 
Table 2.
Discussion
Our findings revealed that the burden of major cardiovascu-
lar risk factors is a linear and strong determinant of mortal-
ity and this burden efficiently prevents reaching 90 years of 
age. Of those having none of these major risk factors 51% 
survived until 90 years of age whereas among those with five 
risk factors only 7% reached that age. Smoking, higher BMI, 
and higher levels of glucose and cholesterol were significant 
predictors for mortality in logistic regression analysis and 
prevented survival to the age of 90. The survivors had signif-
icantly less chronic diseases at the mean age of 73 years, and 
their physical health summary score was also significantly 
higher than among non-survivors suggesting that the longer 
life span was not necessarily of poor quality.
Previous studies have reported that absence of various risk 
factors in midlife is associated with longer life expectancy [11, 
14, 19–21]. Similar to our study, the burden of risk factors has 
been studied in the Framingham Heart Study cohort, but the 
study population was socioeconomically more diverse, and 
the educational level was also found to be associated with 
the survival to exceptional longevity [21]. Also, Yates et al. 
[13] have studied the cumulative effect of cardiovascular risk 
factors, and the results were similar to ours. However, the fac-
tors were measured at age 20 years older than in our cohort, 
and therefore the follow-up time was much shorter, 18 years. 
Yates et al. [13] found that the SRH was significantly higher 
at mean age of 72 among those who survived to the age of 
90. However, there was no difference in SRH between those 
who did or did not reach 90 years in our study with a 44-year 
follow-up. This may be due to the fact that SRH has better 
prognostic value in shorter follow-ups when an individual has 
more accurate information about one’s condition [22].
The study of Wilhelmsen et al. [14] showed that high soci-
oeconomic status and good functional capacity were associ-
ated with the survival to the age of 90 years [14]. In our study, 
the physical health summary score at mean age of 73 was 
higher among those businessmen who reached 90 years of 
age. Also, at the mean age of 73 those who did not survive up 
to that age had more disability and morbidity than survivors.
In midlife, the future survivors to 90 years of age had 
a significantly lower average systolic and diastolic blood 
pressure than non-survivors. However, in contrast to pre-
vious studies [13, 14, 20, 21], blood pressure was not an 
independent predictor of survival to the age of 90. This can 
be explained by correlation of blood pressure with BMI and 
smoking. Furthermore, antihypertensive treatments during 
follow-up may also have diluted potential differences.
The proportion of people who reach 90 years of age 
has increased over the past century [3]. During past dec-
ades the life expectancy has increased especially for the 
people who already have entered old age [3]. The concept 
of successful ageing has been generally associated with 
longevity, highlighting the importance of a very long, 
healthy and active life [3, 4]. The important aspect of this 
paradigm is ‘‘the compression of morbidity’’ explaining 
that disabilities and illnesses can be packed to a minimum 
period in later years and thus expand the healthy life span 
[3, 4]. Our results also support this theory. Prevention and 
advanced treatment of chronic diseases enable an indi-
vidual to maintain functionality and age “successfully” 
[23–32]. Cardiovascular risk factors are well known, and 
their treatments have developed during past decades [33], 
although intensity of treatment varies between various risk 
factors despite effective treatments for, e.g., hypertension 
and dyslipidemia. The obesity epidemic, in turn, continues 
to lack effective treatments [33]. For aiming exceptional 
longevity, our results nevertheless highlight the cumula-
tive effects of common risk factors, which should be taken 
account in practice and in health promotion interventions.
Longitudinal data on a combination of risk factors related 
to survival beyond 90 years have been limited. The strength 
of our study is the very long, 44-year follow-up of initially 
healthy men. Our study sample is also very homogeneous 
representing men from the upper social class which reduces 
confounding by socioeconomic factors. This is obviously also 
a limitation for the generalizability of the results. In addition, 
the cumulative CVD risk factors were only assessed at an 
average age of 50, and the quality of life and morbidity were 
only reported at an average age of 73 years. Furthermore, the 
analyses do not capture the variables of social context.
Implications
Our results show that the burden of midlife risk factors 
is associated with survival to advanced ages, and suggest 
that having a healthy lifestyle in midlife, especially avoid-
ing smoking and obesity, may improve the probability of 
reaching exceptional longevity, 90 years or more. There-
fore, the study gives important incentives for individuals 
and practitioners who wish to promote longevity.
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